NAUT
Nautilus Biotechnology, Inc.
1.96$
+24.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -4.0% | -5.5% | -5.5% | -4.8% | -6.5% | -6.2% | -6.4% | -5.8% | -4.9% | -7.0% | -8.0% | |
| – | -5.3% | +4.7% | -7.7% | -15.6% | -7.9% | +6.6% | +6.4% | -10.9% | -21.1% | -6.7% | -11.3% | |
| – | -73.8% | +32.6% | -3.3% | -82.3% | +527.0% | +20.2% | +3.7% | -30.7% | -48.1% | +18.1% | -10.0% | |
| – | -5.4% | +4.6% | -7.7% | -16.0% | -7.6% | +6.9% | +6.5% | -11.1% | -21.3% | -7.3% | -12.3% | |
| – | -2.1% | -2.6% | -4.3% | -3.2% | -6.2% | -2.2% | -3.5% | -1.0% | +7.4% | -2.3% | -2.7% | |
| – | +2.6% | +1.0% | -5.8% | -0.2% | -11.9% | +6.9% | -0.2% | +10.4% | -11.5% | +4.9% | +3.5% | |
| – | +2.0% | +3.9% | +3.8% | +3.8% | +3.5% | +3.5% | -0.4% | -0.4% | -9.0% | +0.5% | +3.6% | |
| – | +43.5% | +13.5% | -12.5% | -8.6% | -33.6% | -14.8% | +15.8% | -8.3% | +5.6% | +25.8% | -7.7% | |
| – | -4.3% | -6.0% | -5.7% | -5.0% | -6.6% | -6.8% | -6.9% | -6.6% | -7.2% | -8.0% | -9.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.1% | +0.1% | +0.1% | +0.3% | +0.3% | +0.0% | +0.1% | 0.0% | +0.3% | +0.2% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.